Mogu SRL raises € 11 Million in Series A funding round supporting further industrialisation of its mycelium-based technologies and of its positively disruptive product lines, Ephea ™ and Mogu ™
The funding round represents a very important milestone for the pioneering, biotech & biomaterials company, enabling further scaling of its industrial activities (i.e., demo plant), expansion of the Company’s Team,…